AAV Patients and Volunteers needed for a Clinical Trial in Vasculitis

AAV Patients and Volunteers needed for a Clinical Trial in Vasculitis

Patients with anti-neutrophil cytoplasm antibody (ANCA)-associated Vasculitis (AAV) are at risk of disease relapse and so are often kept on long-term medication that suppresses their immune system. These medications may have possible long term harmful effects, but it is hard to tell when to stop treatment without risking disease relapse.…...

Read more

New VCRC Trial Enrolling Patients Now! The Assessment of Prednisone in Remission (TAPIR) Trial

This is a trial for patients with granulomatosis with polyangiitis (Wegener’s). You are invited to participate in a clinical trial being conducted by the Vasculitis Clinical Research Consortium (VCRC) under the direction of Dr. Peter Merkel, from the University of Pennsylvania Medical Center and VCRC Investigators at the University of…...

Read more

GiACTA Study Enrolling Patients – Giant Cell Arteritis Clinical Research Study

double vision? headaches? jaw pain? fever? fatigue? About this Study Giant cell arteritis is a disease where blood vessels become inflamed causing symptoms such as headaches, head tenderness, vision difficulties, facial pain, jaw pain, and fever. Local doctors are conducting this clinical research study for people with giant cell arteritis or GCA.…...

Read more

Cedars-Sinai Medical Center in Los Angeles, CA is conducting several research studies that involve collecting data to better understand the genetics, environmental risks, and outcomes of patients with all forms of Vasculitis

ACR/EULAR endorsed study to develop classification and diagnostic criteria for primary systemic Vasculitis (DCVAS) Background The purpose of this study is to develop new methods of diagnosing and classifying vasculitis. In order to do this, we need to collect information from two groups of people: patients who have vasculitis and…...

Read more

PEXIVAS

PEXIVAS: An International Randomized Controlled Clinical Trial Assessing Plasma Exchange and Steroid Dosing in the Treatment of Severe Anti-Neutrophil Cytoplasm Antibody (ANCA) Associated Vasculitis Introduction: The PEXIVAS study is the largest clinical trial ever to be conducted for vasculitis. The study will study 500 patients with ANCA-associated vasculitis with granulomatosis…...

Read more